Publisher: Springer Verlag
Year of Publication: 2012
Author(s) : Ales Prokop and Seth Michelson
This book explores the fact that the US is currently well ahead of the rest of the world in the development and application of SB and its principles especially as they pertain to basic medical research and development. This lead can be reasoned by the States’ earlier start in the academic arena. However, there is evidence of rapid development in both the UK/EU and Japan, and the gap is narrowing, particularly in the UK. From an industrial point of view, the Pharmaceutical Industry based in the US and UK can capitalize on these opportunities and gain the benefits of this technology. Many educational institutions (particularly their medical divisions), at present, are heavily business-oriented. Thus it is a common realisation that in this particular industrial environment, every dollar counts.
Ref : http://www.strandbooks.com/biology/systems-biology-in-biotech-pharma/_/searchString/pharma